热点栏目 自选股 数据中心 行情中心 资金流向 模拟交易

客户端

　　来源：瑞恩资本RyanbenCapital

　　复星医药(02196.HK)发公告指，上周四(4月17日)斥资3.68亿港元增持复宏汉霖(02696.HK)约1494.07万股非上市股份，平均每股作价24.6港元，卖方为生物科技投资公司HenLink。

　　此外，复星医药在4月11日与无锡通善、上海善梧签订股份转让协议，无锡通善、上海善梧分别同意出售 466.67万股、4.58万股复宏汉霖非上市股份，每股代价为24.6港元，总代价合共为1.16亿港元。

　　复星医药又在4月15日与舟山果运签订股份转让协议，向对方收购138.12万股复宏汉霖非上市股份，每股代价为24.6港元，涉3397.75万港元。

　　上述数项交易完成后，复星医药持有复宏汉霖股权比例会由59.56%增加至63.43%。

海量资讯、精准解读，尽在新浪财经APP

责任编辑：王若云

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.